Status and phase
Conditions
Treatments
About
The aim of the study is to evaluate the safety and efficacy of equimolar conversion from MMF to enteric-coated mycophenolate sodium, in renal transplant patients receiving cyclosporine.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
First or second (single or double) deceased or living donor kidney transplant received at least six months previously;
Exclusion criteria
• Subjects expected to discontinue cyclosporin therapy;
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal